SPL 2.11% 9.3¢ starpharma holdings limited

Ann: AstraZeneca to develop oncology drug using DEP technology, page-32

  1. 2,841 Posts.
    lightbulb Created with Sketch. 139
    I think maybe there are a few too many desperate sellers due to other losses they may have on the market at the moment. Buuyers are taking advantage of that.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.